138 tracked 13F filers disclose a position in BIOA as of the latest SEC 13F filings, a combined $591.4M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Cormorant Asset Management, LP | $50.6M | 2.9M | ▲+42% Added · +850K sh | Q1 2026 | |
| 2 | Sofinnova Investments, Inc. | $56.2M | 2.3M | —Held | Q2 2026 | |
| 3 | BlackRock, Inc. | $39.7M | 2.3M | ▲+48% Added · +740K sh | Q1 2026 | |
| 4 | JANUS HENDERSON GROUP PLC | $36.6M | 2.1M | ▲+412% Added · +1.7M sh | Q1 2026 | |
| 5 | Octagon Capital Advisors LP | $30.6M | 1.7M | ▲+9.4% Added · +150K sh | Q1 2026 | |
| 6 | RA CAPITAL MANAGEMENT, L.P. | $28.9M | 1.7M | ▲New +1.7M sh | Q1 2026 | |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | $23.7M | 1.4M | →First observed position No prior filed position | Q1 2026 | |
| 8 | BALYASNY ASSET MANAGEMENT L.P. | $23.2M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 9 | Polar Capital Holdings Plc | $26.3M | 1.1M | ▼−5.3% Reduced · −60K sh | Q2 2026 | |
| 10 | BRAIDWELL LP | $25.3M | 1.0M | ▼−14% Reduced · −167K sh | Q2 2026 | |
| 11 | STATE STREET CORP | $25.0M | 1.0M | ▲+20% Added · +171K sh | Q2 2026 | |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | $24.6M | 1.0M | ▲+34% Added · +255K sh | Q2 2026 | |
| 13 | Sands Capital Alternatives, LLC | $19.3M | 786K | —Held | Q2 2026 | |
| 14 | ORBIMED ADVISORS LLC | $12.4M | 712K | ▼−10.0% Reduced · −79K sh | Q1 2026 | |
| 15 | D. E. Shaw & Co., Inc. | $12.2M | 699K | ▲+106% Added · +359K sh | Q1 2026 | |
| 16 | Cosmic Management, LLC | $12.3M | 502K | —Held | Q2 2026 | |
| 17 | ADAGE CAPITAL PARTNERS GP, L.L.C. | $8.7M | 500K | ▼−52% Reduced · −550K sh | Q1 2026 | |
| 18 | MILLENNIUM MANAGEMENT LLC | $7.5M | 430K | ▲+88% Added · +202K sh | Q1 2026 | |
| 19 | JACOBS LEVY EQUITY MANAGEMENT, INC | $7.3M | 420K | ▲+26% Added · +86K sh | Q1 2026 | |
| 20 | Walleye Capital LLC | $8.7M | 354K | ▲+134% Added · +203K sh | Q2 2026 | |
| 21 | STEMPOINT CAPITAL LP | $5.9M | 339K | ▲New +339K sh | Q1 2026 | |
| 22 | Integral Health Asset Management, LLC | $7.4M | 300K | ▲New +300K sh | Q2 2026 | |
| 23 | VANGUARD PORTFOLIO MANAGEMENT LLC | $5.0M | 287K | →First observed position No prior filed position | Q1 2026 | |
| 24 | Comprehensive Financial Management LLC | $6.7M | 272K | —Held | Q2 2026 | |
| 25 | FRANKLIN RESOURCES INC | $4.6M | 265K | ▲New +265K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 19 funds opened a new position in BIOA and 19 added to an existing one, while 16 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 69 funds | $47.9B |
| NVIDIA CORPNVDA | 67 funds | $253.5B |
| AMAZON.COM INCAMZN | 65 funds | $126.8B |
| MICROSOFT CORPMSFT | 64 funds | $176.8B |
| BROADCOM INCAVGO | 63 funds | $103.2B |
| META PLATFORMS INC-CLASS AMETA | 63 funds | $70.7B |
| BRISTOL-MYERS SQUIBB COBMY | 63 funds | $8.4B |
| JPMORGAN CHASE & COJPM | 61 funds | $39.5B |
| LAM RESEARCH CORPLRCX | 61 funds | $23.5B |
| MICRON TECHNOLOGY INCMU | 61 funds | $23.4B |
| INTUITIVE SURGICAL INCISRG | 61 funds | $18.1B |
| INTEL CORPINTC | 61 funds | $11.9B |
Ranked by how many of BIOA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Jun 30, 2026 | Barton Shane | Principal Accounting Officer | Sell (S) | 20K | $509K |
| Jun 29, 2026 | Barton Shane | Principal Accounting Officer | Sell (S) | 42K | $1.1M |
| Apr 1, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell (S) | 9K | $157K |
| Mar 2, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell (S) | 7K | $151K |
| Feb 2, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell (S) | 7K | $139K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell (S) | 4K | $86K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell (S) | 12K | $240K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell (S) | 2K | $41K |
| Jan 13, 2026 | GOLDSTEIN DOV A MD | Chief Financial Officer | Sell (S) | 9K | $165K |
| Jan 13, 2026 | Fortney Kristen | Chief Executive Officer, Director | Sell (S) | 233K | $4.2M |
| Jan 2, 2026 | RUBIN PAUL D | Chief Medical Officer | Sell (S) | 7K | $96K |
| Dec 9, 2025 | RUBIN PAUL D | Chief Medical Officer | Sell (S) | 18K | $216K |
Connected entities for BIOA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/BIOA/capital-change-brief"
Use Arkolith's capital_change_brief for BIOA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for BIOA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.